Medicine, Rheumatology Division

Research project

1/21/10 → 1/21/13

Project: Research project

Role of BH3-Domain Proteins in the Effector Phase of RA

Perlman, H. R.

National Institute of Arthritis and Musculoskeletal and Skin Diseases

3/1/09 → 5/31/13

Project: Research project

Prot# ARRAY-797-103: A Phase Ib, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Pharmacokinetics, Safety and Efficacy of ARRY-371797 in Patients with Rheumatoid Arthritis (RA) Receiving Stable Doses of Methotrexate (MTX)

Ruderman, E. M.

Array BioPharma Incorporated

9/9/08 → 9/9/11

Project: Research project

Genetic, Viral and Immunologic Studies in New Zealand Mice

Datta, S. K.

National Institute of Allergy and Infectious Diseases

3/1/04 → 5/31/09

Project: Research project

Prot #2014.009.01: Efficacy and Safety of AbGn-168H in Patients with Active Psoriatic Arthritis: a 24-Week, Open-Label, Multi-center, Phase II Proof of Principle Trial

Ruderman, E. M.

Advanced Clinical LLC, AbGenomics B.V.

3/19/15 → 3/19/18

Project: Research project

Prot# LBRA01: A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects with Rheumatoid Arthritis (RA)

Ruderman, E. M.

Human Genome Sciences, Inc.

1/15/04 → 5/24/07

Project: Research project

Prot# 016.0034: Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1)

Ruderman, E. M.

Mapi USA, Inc., Immunex Corporation

2/22/02 → 9/13/10

Project: Research project

Prot #PCYC-1301-RA: A Randomized, Double-blind, Placebo-controlled Phase 1 Study of the Orally-administered Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-45466 with a Single Ascending Dose Phase in Healthy Subjects and a Multiple Ascending Dose Phase in Su

Ruderman, E. M.

Pharmacyclics, Inc.

6/2/14 → 6/2/17

Project: Research project

Prot# 16.0023: Open-Label Extension Treatment with TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trial 016.0012

Ruderman, E. M.

Immunex Corporation

12/4/00 → 9/10/10

Project: Research project

Prot# A3921029: A Prospective Observational Study to Evaluate Long-Term Safety and Functional Status of Subjects with Rheumatoid Arthritis Previously Enrolled in Studies of cp-690,550

Ruderman, E. M.

ICON Clinical Research, LLC, Pfizer Inc.

4/10/08 → 4/10/11

Project: Research project

Prot# M03-607: A Phase 3 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Active Ankylosing Spondylitis

Ruderman, E. M.

Abbott Laboratories

3/24/04 → 3/24/06

Project: Research project

Prot# ARRAY-797-201: A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of 12 Weeks of Treatment with ARRY-371797 in Patients with Active A

Ruderman, E. M.

Array BioPharma Incorporated

3/11/09 → 3/10/12

Project: Research project

Prot# WA18062: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Reduction of Signs and Symptoms During Treatment with MRA vs. Placebo, in Combination with Methotrexate in Patients with Moderate to Sever

Ruderman, E. M.

Hoffman-La Roche, Inc.

9/23/05 → 9/11/10

Project: Research project

Prot# M02-537: A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients with Moderate to Severely Active Psoriatic Arthritis

Ruderman, E. M.

PPD Development, Abbott Laboratories

9/24/03 → 9/11/10

Project: Research project

Prot# IM101-031-016: A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Use Study to Evaluate the Safety and Tolerability of BMS-188667 Administered Intravenously to Subjects with Active RA with or without Medic

Ruderman, E. M.

Bristol-Myers Squibb Pharmaceutical Research Institute

1/9/03 → 9/11/10

Project: Research project

Genetic, Viral and Immunologic Studies in New Zealand Mice

Datta, S. K.

National Institute of Allergy and Infectious Diseases

3/1/04 → 5/31/09

Project: Research project

Prot# 104RA203: A Phs 2b, Rndmzd, Dbl-Blnd, Plcb-Cntrlld, Mltcntr Stdy to Evlut the Effcy, Sfty, Pharmacokinetics, and Pharmacodynamics of BG9924 When Gvn in Cmbntn w/ Methotrexate to Subs w/ Actv Rheumatoid Arthritis Who Have Had an Indqut Rspnd to Anti-

Ruderman, E. M.

PPD Development, Biogen Inc.

8/7/07 → 8/7/10

Project: Research project

CORRONA Spondyloarthritis and Psoriatic Arthritis (SpA/PsA) Registry

Ruderman, E. M.

Corrona, LLC

8/22/13 → 8/22/25

Project: Research project

Subproject for Unusual Regulatory T cells in Patients with Sever Lupus Following Hematopoietic Stem Cell Transplanation

Datta, S. K.

Lupus Foundation of America, Inc.

10/1/08 → 9/30/09

Project: Research project

Molecular Profiling in Early Diffuse Systemic Sclerosis

Hinchcliff, M. E. & Perlman, H. R.

University of Texas Health Science Center at Houston, Scleroderma Foundation

1/15/15 → 12/31/16

Project: Research project

Hoellen Family Foundation - Arthritis Research 11.2017

Perlman, H. R.

Hoellen Family Foundation

11/1/17 → 5/31/18

Project: Research project

The Role BH3 and Multi BH Domain Genes in Regulating Monocyte Survival and Function

Perlman, H. R.

National Institute of Allergy and Infectious Diseases

9/1/08 → 7/31/10

Project: Research project

IPA for Seok-Jo Kim

Kamp, D. W. & Kim, S.

Jesse Brown VA Medical Center

11/1/16 → 9/30/18

Project: Research project

REF Rheumatology Fellowship Training Award

Pope, R. M.

Rheumatology Research Foundation

7/1/08 → 6/30/09

Project: Research project

The Effects of an Inhibitory Compound to Mcl-1 (GX15-070) on the Rheumatoid Arthritis in Animal Models.

Pope, R. M.

Gemin X Biotechnologies Inc.

4/26/05 → 11/1/07

Project: Research project

Medicine, Rheumatology Division

Grants

Search results